元基因組組定序市場規模、佔有率、成長分析、按產品類型、按技術、按應用、按最終用戶、按地區 - 行業預測，2024-2031 年

2022年全球元基因組體定序市場規模為18億美元，從2023年的21.2億美元成長到2031年的76.8億美元，預計複合年成長率為17.5%。

由於人們對了解複雜微生物群落及其對人類健康、生態系統和工業功能的影響日益感興趣，全球元基因組定序市場正在強勁成長。主要應用包括臨床診斷、農業研究、環境監測和藥物發現。次世代定序技術的採用和定序成本的下降正在推動學術機構、研究機構和製藥公司的市場擴張。此外，感染疾病率的上升和個人化醫療的需求正在推動市場的持續復甦。然而，資料分析、標準化和隱私問題等挑戰可能會為這個動態領域的持續成長帶來風險。整體而言，元基因組組定序可能在各個科學領域中發揮重要作用。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 監管環境
• 專利分析
• 案例研究

依產品類型和複合年成長率分類的元基因組定序市場規模（2024-2031）

• 市場概況
• 裝置
  • 定序系統
  • 樣品製備系統
• 消耗品
  • 試劑和套件
  • 微孔盤
• 軟體
  • 資料分析軟體
  • 儲存和管理軟體

元基因組體定序市場規模：依技術及複合年成長率（2024-2031）

• 市場概況
• 16S RRNA定序
• 鳥槍法宏基因組定序
• 全基因組序列分析
• 元轉錄組學

元基因組體定序市場規模：依應用和複合年成長率（2024-2031）

• 市場概況
• 臨床診斷
  • 感染疾病診斷
  • 癌症診斷
• 藥物發現
  • 微生物組分析
  • 病原鑑定
• 環境應用
  • 土壤微生物分析
  • 水微生物組分析
• 工業用途
  • 生質燃料生產
  • 生物修復

元基因組體定序市場規模：依最終用戶和複合年成長率（2024-2031）

• 市場概況
• 製藥和生物技術公司
  • 藥物開發
  • 品管
• 學術研究所
  • 基礎調查
  • 轉化研究
• 醫院/診所
  • 診斷實驗室
  • 臨床調查

元基因組體定序市場規模與複合年成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Illumina, Inc.（USA）
• Thermo Fisher Scientific Inc.（USA）
• QIAGEN NV（Netherlands）
• PerkinElmer, Inc.（USA）
• Oxford Nanopore Technologies Ltd.（UK）
• Pacific Biosciences of California, Inc.（USA）
• BGI Group（China）
• PSomagen, Inc.（USA）
• Eurofins Scientific（Luxembourg）
• Macrogen, Inc.（South Korea）
• Bio-Rad Laboratories, Inc.（USA）
• Promega Corporation（USA）
• Zymo Research Corporation（USA）
• NuGEN Technologies, Inc.（USA）
• Takara Bio Inc.（Japan）
• Swift Biosciences, Inc.（USA）
• Hamilton Company（USA）

結論和建議

Global Metagenomic Sequencing Market size was valued at USD 1.8 billion in 2022 and is poised to grow from USD 2.12 billion in 2023 to USD 7.68 billion by 2031, growing at a CAGR of 17.5% during the forecast period (2024-2031).

The global metagenomic sequencing market is witnessing robust growth, propelled by the surging interest in understanding complex microbial communities and their effects on human health, ecosystems, and industrial functions. Key applications include clinical diagnostics, agricultural research, environmental monitoring, and drug discovery. The adoption of next-generation sequencing technologies and falling sequencing costs are catalyzing market expansion among academic institutions, research bodies, and pharmaceutical companies. Furthermore, the rising incidence of infectious diseases and the demand for personalized medicine are contributing to continued market vitality. However, challenges such as data analysis, standardization, and privacy issues may pose risks to ongoing growth in this dynamic sector. Overall, metagenomic sequencing is poised to play a crucial role in various scientific fields.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Metagenomic Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Metagenomic Sequencing Market Segmental Analysis

Global Metagenomic Sequencing Market is segmented by product type, technology, application, end-user and region. Based on product type, the market is segmented into instruments, consumables and software. Based on technology, the market is segmented into 16S rRNA sequencing, shotgun metagenomic sequencing, whole-genome sequencing and metatranscriptomics. Based on application, the market is segmented into clinical diagnostics, drug discovery, environmental applications and industrial applications. Based on end-user, the market is segmented into pharmaceutical & biotechnology companies, academic & research institutes and hospitals & clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Metagenomic Sequencing Market

One significant factor fuelling the global metagenomic sequencing market is the rising demand for personalized healthcare. As advancements in metagenomic sequencing allow for an in-depth analysis of the microbial communities inhabiting an individual's body, healthcare professionals can gain critical insights into a person's unique microbiome and its implications for overall health. This information is essential in crafting tailored treatment strategies, assessing disease risk, and selecting the most effective therapies. The growing awareness of the microbiome's influence on health, coupled with the promising advantages posed by metagenomic sequencing, has significantly increased the appetite for this innovative technology in the medical field.

Restraints in the Global Metagenomic Sequencing Market

One of the primary challenges facing the global metagenomic sequencing market is the prohibitive costs linked with the technology. The intricate processes involved in metagenomic sequencing-including sample preparation, data analysis, and interpretation-necessitate the use of advanced equipment and highly skilled personnel. These factors contribute to substantial expenses for both sequencing and the accompanying bioinformatics analysis, thus hindering widespread implementation, particularly in resource-constrained environments. Furthermore, the extensive volume of data produced from metagenomic sequencing demands advanced computational resources for efficient analysis, which exacerbates the overall financial burden associated with the technology and limits its accessibility.

Market Trends of the Global Metagenomic Sequencing Market

The global metagenomic sequencing market is experiencing robust growth, propelled by increasing demand for personalized medicine and improved disease characterization. The advancement of sequencing technologies combined with sophisticated bioinformatics tools has enhanced data analysis capabilities, fostering wider adoption across clinical and research domains. Additionally, the utilization of metagenomic sequencing in environmental monitoring and agricultural applications is contributing to market expansion. Collaborative efforts between research institutions and biotechnology firms are driving innovation, attracting significant investment. However, challenges relating to data management, regulatory compliance, and standardization are critical considerations that could impact the market's trajectory and necessitate ongoing attention for sustained advancement.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Metagenomic Sequencing Market Size by Product Type & CAGR (2024-2031)

• Market Overview
• Instruments
  • Sequencing Systems
  • Sample Preparation Systems
• Consumables
  • Reagents & Kits
  • Microplates
• Software
  • Data Analysis Software
  • Storage & Management Software

Global Metagenomic Sequencing Market Size by Technology & CAGR (2024-2031)

• Market Overview
• 16S Rrna Sequencing
• Shotgun Metagenomic Sequencing
• Whole-Genome Sequencing
• Metatranscriptomics

Global Metagenomic Sequencing Market Size by Application & CAGR (2024-2031)

• Market Overview
• Clinical Diagnostics
  • Infectious Disease Diagnosis
  • Cancer Diagnosis
• Drug Discovery
  • Microbiome Analysis
  • Pathogen Identification
• Environmental Applications
  • Soil Microbiome Analysis
  • Water Microbiome Analysis
• Industrial Applications
  • Biofuel Production
  • Bioremediation

Global Metagenomic Sequencing Market Size by End-User & CAGR (2024-2031)

• Market Overview
• Pharmaceutical & Biotechnology Companies
  • Drug Development
  • Quality Control
• Academic & Research Institutes
  • Basic Research
  • Translational Research
• Hospitals & Clinics
  • Diagnostic Laboratories
  • Clinical Research

Global Metagenomic Sequencing Market Size & CAGR (2024-2031)

• North America (Product Type, Technology, Application, End-User)
  • USA
  • Canada
• Europe (Product Type, Technology, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technology, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technology, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technology, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Group (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PSomagen, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macrogen, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zymo Research Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NuGEN Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Swift Biosciences, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamilton Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations